Dual HER2 Blockade in Patients With HER2-Amplified Metastatic
HER2 in Colorectal Cancer: The Long and Winding Road From Negative Predictive Factor to Positive Actionable Target | American Society of Clinical Oncology Educational Book
HER2 as an Emerging Oncotarget for Colorectal Cancer Treatment After Failure of Anti‐Epidermal Growth Factor Receptor Therapy | Semantic Scholar
Clinical significance of HER2 and EGFR expression in colorectal cancer patients with ovarian metastasis | BMC Clinical Pathology | Full Text
HER2 Status in Colorectal Cancer: Its Clinical Significance and the Relationship between HER2 Gene Amplification and Expression | PLOS ONE
![HER2 and BRAF mutation in colorectal cancer patients: a retrospective study in Eastern China [PeerJ]](https://dfzljdn9uc3pi.cloudfront.net/2020/8602/1/fig-1-full.png "HER2 and BRAF mutation in colorectal cancer patients: a retrospective study in Eastern China [PeerJ]")
HER2 and BRAF mutation in colorectal cancer patients: a retrospective study in Eastern China [PeerJ]
Prevalence, prognosis and predictive status of HER2 amplification in anti-EGFR-resistant metastatic colorectal cancer | SpringerLink
![HER2 and BRAF mutation in colorectal cancer patients: a retrospective study in Eastern China [PeerJ]](https://dfzljdn9uc3pi.cloudfront.net/2020/8602/1/fig-5-2x.jpg "HER2 and BRAF mutation in colorectal cancer patients: a retrospective study in Eastern China [PeerJ]")
HER2 and BRAF mutation in colorectal cancer patients: a retrospective study in Eastern China [PeerJ]
HER2 Biomarker | Colorectal Cancer Alliance
HER2 expression and copy number alterations in colorectal cancer (CRC).... | Download Scientific Diagram
Q&A column - CAP TODAY
Dual-targeted therapy with trastuzumab and lapatinib in treatment-refractory, KRAS codon 12/13 wild-type, HER2-positive metastatic colorectal cancer (HERACLES): a proof-of-concept, multicentre, open-label, phase 2 trial - The Lancet Oncology
HER2 G776S mutation promotes oncogenic potential in colorectal cancer cells when accompanied by loss of APC function | Scientific Reports
Dual HER2 Blockade in Patients With HER2-Amplified Metastatic
Anti-HER2 Agents Gain Ground in Colorectal Cancer
Pertuzumab plus trastuzumab for HER2-amplified metastatic colorectal cancer (MyPathway): an updated report from a multicentre, open-label, phase 2a, multiple basket study - The Lancet Oncology
HER2 Biomarker in Colon Cancer | Know Your Biomarker
Frontiers | Human Epidermal Growth Factor Receptor 2 Overexpression and Amplification in Patients With Colorectal Cancer: A Large-Scale Retrospective Study in Chinese Population
Assessment of a HER2 scoring system for colorectal cancer: results from a validation study | Modern Pathology
A HER2-targeting antibody-MMAE conjugate RC48 sensitizes immunotherapy in HER2-positive colon cancer by triggering the cGAS-STING pathway | Cell Death & Disease
HER2 in Colorectal Cancer: The Long and Winding Road From Negative Predictive Factor to Positive Actionable Target | American Society of Clinical Oncology Educational Book
Life | Free Full-Text | HER2 in Metastatic Colorectal Cancer: Pathology, Somatic Alterations, and Perspectives for Novel Therapeutic Schemes
Comprehensive assessment of HER2 alteration in a colorectal cancer coh | CMAR
HER2/neu testing in primary colorectal carcinoma | British Journal of Cancer
Tucatinib Approved for HER2-Positive Colorectal Cancer - NCI
Fulfilling the potential of HER2-targeting in colorectal cancer: update on detection and management - YouTube
